Kalypsys, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://kalypsys.com
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
Phase 2
Completed
- Conditions
- Postherpetic NeuralgiaShinglesHerpes ZosterNeuropathic Pain
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Kalypsys, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00576108
- Locations
- 🇺🇸
United Bioscience Corporation, Kansas City, Missouri, United States